Medtronic Announces Scientific Data Presentations at the American Diabetes Association 78th Scientific Sessions Meeting
June 19 2018 - 10:00AM
Medtronic Will
Host a Webcast of Its Diabetes Group Analyst and Investor
Briefing
on Monday, June 25 from 9 - 10 a.m. EDT
DUBLIN - June 19, 2018 -
Medtronic plc (NYSE:MDT), the global leader in medical technology,
today announced its schedule of notable sessions that will be
presented at the 78th Scientific Sessions of the American Diabetes
Association, in Orlando, June 22-26. A significant portion of the
scientific data being presented focuses on Medtronic's insulin pump
systems, including the MiniMed(TM) 670G system, the world's first
hybrid closed-loop system. Data will also be presented on the
Sugar.IQ(TM) app, powered by IBM Watson technology, as well as
managing glucose control using the Guardian(TM) Connect continuous
glucose monitoring (CGM) system.
Scientific
Presentations
Cognitive Science
- "Real-World Assessment of Sugar.IQ with Watson: A
Cognitive Computing-Based Diabetes Management Solution" - oral
presentation by Yuxiang Zhong on Friday, June 22 from 6 - 6:15 p.m.
W311, 16-OR.
Continuous Glucose Monitoring (CGM)
- "Real-world Avoidance of Glucose Excursions with
the Guardian Connect CGM System's Predictive Alerts" - poster
presentation by Sinu Bessy Abraham on Saturday, June 23 from 11:30
a.m. - 12:30 p.m. Poster Hall, 953-P.
- "Fourth-Generation Glucose Sensor with an
Advanced Algorithm Featuring No Calibrations and Optional
Calibration Modes of Operation" - poster presentation by Dr. Andrea
Varsavsky on Saturday, June 23 from 11:30 a.m. - 12:30 p.m. Poster
Hall, 936-P.
Insulin Pump Therapy
-
"Real-World Data from the MiniMed 670G System
Commercial Launch: Patients Previously Using MDI Therapy" - oral
presentation by Dr. Scott W. Lee on Sunday, June 24 from 3 - 3:15
p.m. W308, 209-OR.
-
"Real-World Data from the MiniMed 670G System
Commercial Launch" - poster presentation by Pratik Agrawal on
Sunday, June 24 from 12 - 1 p.m. (Poster Hall, 960-P and 994-P
covering 1,052 patients) and a moderated poster presentation on
Monday, June 25 from 12-1 p.m. (ePoster Theater B, 960-P).
-
"The MiniMed 670G Hybrid Closed-Loop (HCL)
System and Patient-Reported Outcomes Concerning Quality of Life
Measures" - poster presentation by Shweta Gopalakrishnan on Sunday,
June 24 from 12 - 1 p.m. (Poster Hall, 963-P) and moderated poster
presentation on Monday, June 25 from 12 - 1 p.m. (ePoster Theater
B, 663-P).
-
"Overnight Insulin Delivery and Glucose in
Children Using the MiniMed 670G System" - oral presentation by Dr.
Anirban Roy on Sunday, June 24 from 2:15 - 2:30 p.m. W308,
206-OR.
-
"Overnight to Early-Morning Glycemic Outcomes in
Children Using the MiniMed 670G Hybrid Closed-Loop (HCL) System" -
oral presentation by Dr. Gregory P. Forlenza on Sunday, June 24
from 6 - 6:15 p.m. W204, 236-OR.
-
"Characterization of the Predictive Low Glucose
Management (PLGM) Algorithm of the MiniMed 670G System in Children"
- poster presentation by Dr. Dorothy I. Shulman on Sunday, June 24
from 12 - 1 p.m (Poster Hall, 965-P) and moderated poster
presentation on Monday, June 25 from 12-1 p.m. (ePoster Theater B,
965-P).
-
"Postprandial Response in Children Using the
MiniMed 670G System" - poster presentation by Dr. Di Wu on Sunday,
June 24 from 12 - 1 p.m. Poster Hall, 969-P.
-
"MiniMed Veo(TM) Insulin Pump Analysis for
Real-World Non-Adjunctive CGM Insights" - poster presentation by
Dr. Robert A. Vigersky on Saturday, June 23 from 11:30 a.m. - 12:30
p.m. Poster Hall, 920-P.
Company Exhibit Floor
Presentations
Medtronic will be showcasing their newest and most advanced
technologies at Booth #639, including the MiniMed 670G system as
well as the Guardian Connect continuous glucose monitoring (CGM)
system with the Sugar.IQ intelligent diabetes assistant app.
Additionally, Medtronic will host a series of
presentations at the booth from Saturday through Monday, providing
an opportunity for attendees to learn about the application of
Medtronic technologies from experts. A full list of presentations
is below:
- MiniMed 670G System Real World Data & Patient
Stories - Saturday, June 23 at 10:30 a.m. and Sunday, June 24 at
1:30 p.m.
- Digital Therapeutics: Improving Adherence and
Outcomes - Saturday, June 23 at 3 p.m.
- Creating Personalized Treatment Plans Through
iPro(TM)2 Professional CGM - Sunday, June 24 at 10:30 a.m.
- Guardian Connect CGM & Sugar.IQ Insights -
Sunday, June 24 at 3 p.m. and Monday, June 25 at 10:30 a.m. and
1:30 p.m.
Finally, Medtronic will also be hosting two
Product Theater Presentations. The date and time for each
presentation is as follows:
- "The Guardian Connect System: Utilizing
predictive alerts and data backed insights to help with diabetes
management" - presented by Dr. Timothy S. Bailey and Huzefa
Neemuchwala on Sunday, June 24 at 10:15 a.m.
- "MiniMed 670G System: Increasing time in range
with automated insulin delivery" - presented by Drs. Anders L.
Carlson and Jennifer L. Sherr on Monday, June 25 at 10:15 a.m.
Analyst and Investor
Briefing
Medtronic will host a webcast to highlight its Diabetes Group on
Monday, June 25, from 9 a.m. to 10 a.m. EDT. The webcast will
feature remarks from Medtronic management, including comments on
Medtronic's clinical data, product pipelines, and market outlooks.
The live audio webcast can be accessed by clicking on the Investor
Events link at http://investorrelations.medtronic.com on June 25.
Within 24 hours of the webcast, a replay will be available on the
same webpage. This event is not part of the official ADA
Scientific Sessions.
Sponsored Events
Medtronic is also proud to serve as a sponsor for three events at
this year's ADA:
- Women Interprofessional Networking (WIN) ADA
Networking Reception - taking place Friday, June 22 from 6:30 -
8:30 p.m. EDT at the Orange County Convention Center in the Third
Level Foyer
- 12th Annual
Diabetes Forum - taking place on Monday, June 25 from 6:30 - 8:30
p.m. at the Rosen Centre Hotel
- Musings Under the Moon - taking place on Monday,
June 25 from 9:30 p.m. - 1:30 a.m. at BB King's Blues Club
About the Diabetes Group at
Medtronic (www.medtronicdiabetes.com)
Medtronic is working together with the global community to change
the way people manage diabetes. The company aims to transform
diabetes care by expanding access, integrating care and improving
outcomes, so people living with diabetes can enjoy greater freedom
and better health.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 86,000 people worldwide, serving physicians,
hospitals and patients in more than 150 countries. The company is
focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Janet Cho
Public Relations
+1-818-576-5014
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2024 to May 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From May 2023 to May 2024